Archive › AXGN
AXGN trade ideas: every closed DuckWise idea on AxoGen, Inc.
DuckWise has published 1 idea on AxoGen, Inc. (AXGN, Stock) that has closed between October 2020 and November 2020. Each is listed below with the levels published before the position was taken and its result at close — 1 in profit, 0 at a loss.
| Opened | Closed | Side | Entry | Stop | Projection | Close | Result | Days |
|---|---|---|---|---|---|---|---|---|
| Oct 6, 2020 | Nov 9, 2020 | Long | 12.12 | — | 15.50 | 15.10 | +24.59% | 34 |
Prices in US dollars. Prices are as traded on the day. Result is the price change from the published entry to the published close plus dividends received while the idea was held (paid, for shorts), before fees, taxes and slippage. How results are counted.
AXGN questions and answers
Has DuckWise published trade ideas on AXGN?
Yes. DuckWise has published 1 idea on AxoGen, Inc. (AXGN) that closed between October 2020 and November 2020: 1 closed in profit and 0 at a loss. The average result was +24.59% from the published entry to the published close, dividends included.
What was the latest closed DuckWise idea on AXGN?
A long idea opened on October 6, 2020 with an entry of $12.12 and a price projection of $15.50. It closed on November 9, 2020 at $15.10, a result of +24.59% after 34 days.
How long did DuckWise hold its AXGN ideas?
The typical AXGN idea was held about 34 days from entry to close. DuckWise ideas are swing and position trades, not day trades.
Is there an open DuckWise idea on AXGN right now?
Not at the moment. When DuckWise publishes a new idea on AXGN, app subscribers get a push notification; it appears on this page once it closes.
Is this page a stock forecast for AXGN or a recommendation to buy it?
No. This page records closed ideas only. Each price projection was a published level for a model idea, not a forecast of where AXGN will trade. The research is general and impersonal, not a recommendation to buy or sell AXGN or any other security.
More trade ideas on the record
- AMZN Amazon.com, Inc. · 25 ideas
- ANTM Elevance Health Inc. · 1 idea
- ATVI Activision Blizzard, Inc. · 1 idea
- AYX Alteryx, Inc. · 2 ideas
- BABA Alibaba Group Holding Limited · 12 ideas
- BAND Bandwidth Inc. · 1 idea
- TSLA Tesla, Inc. · 22 ideas
- CRM Salesforce, Inc. · 18 ideas
- LRCX Lam Research Corporation · 16 ideas
- GOOG Alphabet Inc. · 15 ideas
- ON ON Semiconductor Corporation · 15 ideas
- AAPL Apple Inc. · 14 ideas
- AMD Advanced Micro Devices, Inc. · 14 ideas
- JD JD.com, Inc. · 14 ideas
Every ticker in the archive · Track record by year
About AxoGen, Inc.
Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avance Nerve Graft, a processed nerve allograft intended for the surgical repair of peripheral nerve discontinuities; Axoguard Nerve Connector, a coaptation aid used to align and connect severed peripheral nerve ends in a tensionless repair; and Axoguard Nerve Protector, a product used to protect and wrap damaged peripheral nerves and reinforce reconstructed nerve gaps. Does not pay dividends.
These are closed ideas, published for the record. They are general and impersonal research, not a recommendation to buy or sell AXGN or any other security.
DuckWise